- Sections
- A - Nécessités courantes de la vie
- A61K - Préparations à usage médical, dentaire ou pour la toilette
- A61K 39/155 - Paramyxoviridae, p. ex. virus de para-influenza
Détention brevets de la classe A61K 39/155
Brevets de cette classe: 1012
Historique des publications depuis 10 ans
|
55
|
47
|
64
|
72
|
56
|
54
|
63
|
91
|
65
|
15
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Glaxosmithkline Biologicals S.A. | 1608 |
76 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2966 |
45 |
| Modernatx, Inc. | 1287 |
27 |
| Curevac SE | 281 |
26 |
| Novavax, Inc. | 172 |
25 |
| University of Georgia Research Foundation, Inc. | 1062 |
24 |
| Janssen Vaccines & Prevention B.V. | 293 |
22 |
| Institute for Research in Biomedicine | 101 |
18 |
| Zoetis Services LLC | 1528 |
17 |
| Intervet Inc. | 912 |
15 |
| Pfizer Inc. | 3394 |
12 |
| Boehringer Ingelheim Animal Health USA Inc. | 419 |
12 |
| Boehringer Ingelheim Vetmedica GmbH | 1282 |
11 |
| Merck Sharp & Dohme LLC | 3726 |
10 |
| Baylor College of Medicine | 988 |
9 |
| Intervet International B.V. | 1328 |
9 |
| Crucell Holland B.V. | 84 |
8 |
| GenVec, Inc. | 53 |
8 |
| The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. | 382 |
8 |
| ADMA Biomanufacturing, LLC | 32 |
8 |
| Autres propriétaires | 622 |